Current progression and prospect in the targeting therapy of age-related macular degeneration
10.3760/cma.j.issn.2095-0160.2012.01.001
- VernacularTitle:新生血管性年龄相关性黄斑变性药物治疗的进步和展望
- Author:
Xiao-xin, LI
;
Yu-jing, BAI
- Publication Type:Journal Article
- Keywords:
Age-related macular degeneration;
Choroidal neovascularization;
Targeting therapy
- From:
Chinese Journal of Experimental Ophthalmology
2012;30(1):1-6
- CountryChina
- Language:Chinese
-
Abstract:
Age-related macular degeneration (AMD) has become a leading cause of irreversible visual loss in senior population and a serious issue of public health as the aging of society worldwide,especially wet AMD.Wet AMD is characterized by choroidal neovascularization(CNV)with a rapidly developing process andsevere impairment of visual acuity.The effective therapy that can destroy choroidal neovascularization and improve visual acuity for very long time is lack.In the recent 20 years,more attentions focuse on the treatment of choroidal neovascularization.From bench to bedside,the research on targeted treatment of angiogenesis brings the bloom of wet AMD medical therapy.This paper will summarize the update information of wet AMD.
